Advantages and Disadvantages of Various methods for Dupuytren’s Contracture


Cite item

Full Text

Abstract

Current methods for Dupuytren’s contracture treatment - conservative, radical surgical, low invasive are presented. Their advantages and disadvantages are discussed. Unfortunately no one method allows to avoid relapses at various terms after treatment. In the lack of common approach to the choice of treatment tactics the low invasive techniques such as needle aponeurotomy, collagenase injections, percutaneousaponeurotomywith lipofilling (lipografting)are becoming more popular.

About the authors

A. A Ulishchenko

N.N. Priorov Central Institute of Traumatology and Orthopaedics

Email: dr.ales@yahoo.com
postgraduate, chair of traumatology and orthopaedics, RUDN University Moscow, Russia

I. O Golubev

N.N. Priorov Central Institute of Traumatology and Orthopaedics

доктор мед. наук, зав. отделением микрохирургии и травмы кисти ЦИТО им. Н.Н. Приорова, профессор кафедры травматологии и ортопедии РУДН Moscow, Russia

References

  1. Lanting R., Broekstra D.C., Werker P.M. et al. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of western countries. Plast. Reconstr. Surg. 2014; 133 (3): 593-603. doi: 10.1097/01.prs.0000438455.37604.0f.
  2. Микусев И.Е. Причины и профилактика повторных операций при контрактуре Дюпюитрена. Казанский медицинский журнал. 1995; LXXVI (5): 385-7.
  3. Сиваконь С.В. Комплексное хирургическое лечение контрактуры Дюпюитрена. Автореф. дис.. д-ра мед. наук. М.; 2004.
  4. Тарик Я.М. Оперативное лечение тяжелых форм контрактуры Дюпюитрена. Автореф. дис. … канд. мед. наук. М.: 2005.
  5. Беюл А.П. Оперативное лечение дюпюитреновской контрактуры. В кн.: Сборник работ хирургических клиник І ММИ. М.; 1938: 82-96.
  6. Воробьев В.Н. Контрактура Дюпюитрена и ее хирургическое лечение. Вестник хирургии. 1957; 12: 41-6.
  7. Брянцева Л.Н. Контрактура Дюпюитрена. Л.: Медицина; 1963.
  8. Meyerding H.A., Black J.R., Broders A.C. The etiology and pathology of Dupuytren’s contracture. Surg. Gynecol. Obs tet. 1941; 72: 582-90.
  9. James J., Tubiana R. Dupuytren’s disease. Rev. Chir. Orthop. Reparatrice Appar. Mot. 1952; 38 (3-4): 352-406.
  10. McCash C.R. The open palm technique in Dupuytren’s contracture. Br. J. Plast. Surg. 1964; 17: 271-80.
  11. Burge P., Hoy G., Regan P., Milne R. Smoking, alcohol and the risk of Dupuytren’s contracture. J. Bone Joint Surg. Br. 1997; 79 (2): 206-10.
  12. Noble J., Arafa M., Royle S.G. et al. The association between alcohol, hepatic pathology and Dupuytren’s disease. J. Hand Surg. Br. 1992; 17 (1): 71-4.
  13. Smith S.P., Devaraj V.S., Bunker T.D. The association between frozen shoulder and Dupuytren’s disease. J. Shoulder Elbow Surg. 2001; 10 (2): 149-51.
  14. Bonnici A.V., Birjandi F., Spencer J.D. et al. Chromosomal abnormalities in Dupuytren’s contracture and carpal tunnel syndrome. J. Hand Surg. Br. 1992; 17 (3): 349-55.
  15. Mikkelsen O.A. Dupuytren’s diseaseinitial symptoms, age of onset and spontaneous course. Hand. 1977; 9 (1): 11-5.
  16. Langemak G.E. Zur Thiosinaminbehandlung der Dupuytren’schen Faschienkontraktur. M_nchener Med Wochenschr. 1907; 54: 1380.
  17. Dominguez-Malagon H.R., Alfeiran-Ruiz A., Chavarria- Xicotencatl P. Duran-Hernandez M.S. Clinical and cellular effects of colchicine in fibromatosis. Cancer. 1992; 69 (10): 2478-83.
  18. Murrell G.A.C., Francis M.J.O., Bromley L. The collagen changes of Dupuytren’s contracture. J. Hand Surg. Br. 1991; 16: 263-6.
  19. Ketchum L.D., Donahue T.K. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J. Hand Surg. Am. 2000; 25: 1157-62. doi: 10.1053/ jhsu.2000.18493.
  20. Rayan G.M. Dupuytren’s disease: anatomy, pathology, presentation, and treatment. J. Bone Joint Surg. Am. 2007; 89 (1): 189-98.
  21. Evans R.B., Dell P.C., Fiolkowski P. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren’s contracture. J. Hand Ther. 2002; 15 (4): 331-9.
  22. Larson D., Jerosch-Herold C. Clinical effectiveness of postoperative splinting after surgicalrelease of Dupuytren’s contracture: a systematic review. BMC Musculoskelet. Disord. 2008; 9: 104. doi: 10.1186/1471- 2474-9-104.
  23. Jerosch-Herold C., Shepstone L., Chojnowski A.J., Larson D. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s Contracture a pragmatic, multicentre, randomized controlled trial. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 323-32. doi.org/10.1007/978-3-642-22697-7_41.
  24. Rigotti G., Marchi A., Galie_ M. et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose derived adult stem cells. Plast. Reconstr. Surg. 2007; 119 (5): 1409-22. doi: 10.1097/01.prs.0000256047.47909.71.
  25. Keilholz L., Seegenschmiedt M.H., Born A.D., Sauer R. Radiotherapy in the early stages of Dupuytren’s disease: indication, technique, long-term results. Strahlenther Onkol. 1997; 173: 27-35.
  26. Betz N., Ott O.J., Adamietz B. et al. Radiotherapy in early-stage Dupuytren’s contracture. Long-term results after 13 years. Strahlenther Onkol. 2010; 186 (2): 82-90. doi: 10.1007/s00066-010-2063-z.
  27. Seegenschmiedt M.H., Keilholz L., Wielpьtz M. et al. Long-term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 349-371. doi.org/10.1007/978-3-642-22697-7_44.
  28. Ball C., Izadi D., Verjee L.S., Chan J. Systematic review of non-surgical treatments for early dupuytren’s disease. BMC Musculoskelet. Disord. 2016; 17 (1): 345. doi: 10.1186/s12891-016-1200-y.
  29. Badalamente M.A., Hurst L.C. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J. Hand Surg. Am. 2007; 32: 767-74. doi: 10.1016/j.jhsa.2007.04.002.
  30. Smeraglia F., Del Buono A., Maffulli N. Collagenase clostridium histolyticum in Dupuytren’s contracture: a systematic review. Br. Med. Bull. 2016; 118 (1): 149-58. 1-10. doi: 10.1093/bmb/ldw020.
  31. Hurst L.C., Badalamente M.A. et al. CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N. Engl. J. Med. 2009; 361 (10): 968-79. doi: 10.1056/NEJMoa0810866.
  32. Coleman S., Gilpin D., Kaplan F.T. et al. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J. Hand Surg. Am. 2014; 39 (1): 57-64. doi: 10.1016/j. jhsa.2013.10.002.
  33. Mickelson D.T., Noland S.S., Watt A.J. et al. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for Dupuytren contracture. J. Hand Surg. Am. 2014; 39 (10): 1933-41.e1. doi: 10.1016/j.jhsa.2014.07.010.
  34. Ашкенази А.И. Хирургия кистевого сустава. Серия: Библиотека практического врача. М.: Медицина; 1990.
  35. Волкова A.M. Хирургия кисти. т. 2. Свердловск. 1993: 10-58.
  36. Van Rijssen A.L., Ter Linden H., Werker P.M.N. 3-year results of first-ever randomised clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 281-8. doi: 10.1007/978-3-642-22697-7_35.
  37. Chick L.R., Lister G.D. Surgical alternatives in Dupuytren’s contracture. Hand Clin. 1991; 7 (4): 715-9.
  38. Clibbon J.J. Logan A.M. Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal flexion contracture. J. Hand Surg. Br. 2001; 26 (4): 360-1. doi: 10.1054/jhsb.2001.0602.
  39. Misra A., Jain A. Ghazanfar R. et al. Predicting the out- come of surgery for the proximal interphalangeal joint in Dupuytren’s disease. J. Hand Surg. 2007; 32 (2): 240-5. doi: 10.1016/j.jhsa.2006.11.015.
  40. Denkler K. Surgical complications associated with fasciectomy for Dupuytren’s disease: a 20 year review of the english literature. Eplasty. 2010; 10: e15.
  41. Pess G.M., Pess R.M., Pess R.A. Results of needle aponeurotomy for Dupuytren сontracture in over 1,000 fingers. J. Hand Surg. Am. 2012; 37 (4): 651-6. doi: 10.1016/j. jhsa.2012.01.029.
  42. Foucher G., Cornil C.H., Lenoble E. ‘Open palm’ technique in Dupuytren’s disease. Postoperative complications and results after more than 5 years. Chirurgie. 1992; 118 (4): 18-94 [Article in French].
  43. Ketchum L. Expanded Dermofasciectomies and full- thickness grafts in the treatment of Dupuytren’s contracture: a 36-year experience. In: Eaton C., Seegenschmiedt M., Bayat A., Gabbiani G., Werker P., Wach W., eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Principles, Research, and Clinical Perspectives. Springer, Berlin, Heidelberg; 2012: 213-20. doi.org/10.1007/978-3-642-22697-7_26
  44. Armstrong J.R., Hurren J.S., Logan A.M. Dermofasciectomy in the management of Dupuytren’s disease. J. Bone Joint Surg. Br. 2000; 82 (1): 90-4.
  45. Harrison S.H., Morris A. Dupuytren’s Contracture: the dorsal transposition flap. Hand. 1975; 7 (2): 145-9.
  46. Laurenza F., Gensini A. Rotation of a skin flap from the side of the finger to the volar surface in the treatment of Dupuytren’s disease. Ital. J. Orthop. Traumatol. 1992; 18 (1): 37-41.
  47. Ozdemir O., Co_ckunol E., I_cik B. The surgical treatment of Dupuytren contracture with the reverse flow dorsal metacarpal island flap. Tech. Hand Up Extrem. Surg. 2000; 4 (2): 137-40.
  48. Lukas B., Lukas M. Flap plasty in advanced Dupuytren’s disease. Oper. Orthop. Traumatol. 2016; 28 (1): 20-9. doi: 10.1007/s00064-015-0435-3.
  49. Жигало А.В. Особенности хирургической тактики при лечении больных с тяжелыми формами контрактуры Дюпюитрена. Автореф. дис. … канд. мед. наук. СПб; 2010.
  50. Badois F.J., Lermusiaux J.L., Masse C., Kuntz D. Non- surgical treatment of Dupuytren disease using needle fasciotomy. Rev. Rhum. Ed Fr. 1993; 60 (11): 808-13 [Article in French].
  51. Van Rijssen A.L., Gerbrandy F.S., Ter Linden H. et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J. Hand Surg. Am. 2006; 31 (5): 717-25. doi: 10.1016/j.jhsa.2006.02.021.
  52. Van Rijssen A.L., Werker P.M. Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg. Br. 2006; 31 (5): 498-50.
  53. Chen N.C., Srinivasan R.C., Shauver M.J., Chung K.C. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren’s contracture. Hand (NY). 2011; 6 (3): 250-5. doi 10.1007/ s11552-011-9326-8
  54. Hovius S.E., Kan H.J., Smit X. et al. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast. Reconstr. Surg. 2011; 128 (1): 221-8.
  55. Coleman S.R. Structural fat grafting: More than a permanent filler. Plast. Reconstr. Surg. 2006; 118 (3 Suppl): 108S-20S. doi: 10.1097/01.prs.0000234610.81672.e7.
  56. Rigotti G., Marchi A., Galie_ M. et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose derived adult stem cells. Plast. Reconstr. Surg. 2007; 119 (5): 1409-22. doi: 10.1097/01.prs.0000256047.47909.71.
  57. Khouri R.K., Smit J.M., Cardoso E. et al. Percutaneous aponeurotomy and lipofilling: A regenerative alternative to flap reconstruction? Plast. Reconstr. Surg. 2013; 132 (5): 1280-90. doi: 10.1097/PRS.0b013e3182a4c3a9.
  58. Kan H.J., Selles R.W., van Nieuwenhoven C.A. et al. Percutaneous aponeurotomy and lipofilling (PALF) versus limited fasciectomy in patients with primary Dupuytren’s contracture: prospective, randomized, controlled trial. Plast. Reconstr. Surg. 2016; 137 (6): 1800-12. doi: 10.1097/PRS.0000000000002224.
  59. Lipman M.D., Carstensen S.E., Deal D.N. Trends in the treatment of Dupuytren disease in the United States between 2007 and 2014. Hand (N Y). 2017; 12 (1): 13-20. doi: 10.1177/1558944716647101.
  60. Магомедов Р.О., Микусев Г.И., Байкеев Р.Ф. и др. Регистр болезни (контрактуры) Дюпюитрена по Республике Татарстан: эффективность хирургического лечения. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2013; 1: 10-7.

Copyright (c) 2017 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies